1 Hoffman HM, Mueller JL, Broide DH, et al.Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet, 2001, 29: 301-305.
2 Hansson GK, Klareskog L.Pulling down the plug on atherosclerosis: cooling down the inflammasome. Nat Med, 2011, 17:790-791.
3 Schroder K, Zhou R, Tschopp J.The NLRP3 inflammasome: a sensor for metabolic danger? Science, 2010, 327(5963): 296-300.
4 Szabo G, Csak T.Inflammasomes in liver diseases. J Hepatol, 2012, 57:642-654.
5 Kersse K, Bertrand MJ, Lamkanfi M, et al.NOD-like receptors and the innate immune system: coping with danger, damage and death. Cytokine Growth Factor Rev, 2011,22:257-276.
6 Franchi L, Eigenbrod T, Munoz-Planillo R, et al.The inflammasome: a caspase-l-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol, 2009, 10: 241-247.
7 Vyleta ML, Wong J, Magun BE.Suppression of ribosomal function triggers innate immune signaling through activation of the NLRP3 inflammasome. PLoS One, 2012,7:e36044.
8 Boaru SG, Borkham-Kamphorst E, Van de Leur E, et al. NLRP3 inflammasome expression is driven by NF-κB in cultured hepatocytes. Biochem Biophys Res Commun,2015,458:700-706.
9 Atianand MK, Rathinam VA, Fitzgerald KA.SnapShot: inflammasomes. Cell, 2013,153:272.
10 Abderrazak A, Syrovets T, Couchie D, et al.NLRP3 inflammasome: From a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases. Redox Biology, 2015, 4:296-307.
11 Lee GS, Subramanian N, Kim AI, et al.The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature, 2012,492(7427):123-127.
12 Zambetti LP, Laudisi F, Licandro G, et al.The rhapsody of NLRPs: master players of inflammation..and a lot more. Immunol Res,2012,53:78-90.
13 Li H, Ambade A, Re F.Cutting edge: necrosis activates the NLRP3 inflammasome, J Immunol, 2009,183:1528-1532.
14 Ciraci C, Janczy JR, Sutterwala FS, et al.Control of innate and adaptive immunity by the inflammasome. Microbes Infect, 2012,14:1263-1270.
15 Pétrilli V, Papin S, Dostert C, et al.Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ, 2007, 14:1583-1589.
16 Gross O, Poeck H, Bscheider M, et al., Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence, Nature, 2009, 459(7245): 433-436.
17 Hornung V, Bauernfeind F, Halle A,et al.Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol,2008,9:847-856.
18 Shimada K, Crother TR, Karlin J, et al.Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity,2012, 36: 401-414.
19 Stehlik C, Dorfleutner A.COPs and POPs: modulators of inflammasome activity. J Immunol, 2007,179: 7993-7998.
20 Shi M, Deng W, Bi E, et al.TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation. Nat Immunol, 2008,9: 369-377.
21 Sutterwala FS, Haasken S, Cassel SL.Mechanism of NLRP3 inflammasome activation. Ann N Y Acad Sci, 2014,1319:82-95.
22 Bauernfeind F,Rieger A,Schildberg FA,et al.NLRP3 inflammasome activity is negatively controlled by miR-223. J Immunol,2012,189:4175-4181.
23 Hernandez-Cuellar E, Tsuchiya K, Hara H, et al.Cutting edge: nitric oxide inhibits the NLRP3 inflammasome. J Immunol, 2012,189:5113-5117.
24 Guarda G, Dostert C, Staehli F, et al.T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature, 2009,460(7252):269-273.
25 Boaru SG, Borkham-Kamphorst E, Tihaa L, et al.Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease. J Inflamm (Lond),2012,9:49.
26 Stravitz RT, Sanyal AJ, Reisch J, et al.Effects of N-acetylcysteine on cytokines in non-acetaminophen acute liver failure: potential mechanism of improvement in transplant-free survival. Liver Int, 2013,33:1324-1331.
27 Xing T, Li L, Cao H, et al.Altered immune function of monocytes in different stages of patients with acute on chronic liver failure. Clin Exp Immunol, 2007,147:184-188.
28 Hu J, Yan D, Gao J, et al.rhIL-1Ra reduces hepatocellular apoptosis in mice with acetaminophen-induced acute liver failure. Lab Invest,2010,90:1737-1746.
29 Kim SJ, Lee SM.NLRP3 inflammasome activation in D-galactosamineand lipopolysaccharide-induced acute liver failure:Role of heme oxygenase-1. Free Radic Biol Med,2013,65:997-1004.
30 Leemans JC, Cassel SL, Sutterwala FS.Sensing damage by the NLRP3 inflammasome. Immunol Rev, 2011,243:152-162.
31 Kim HY, Kim SJ, Lee SM.Activation of NLRP3 and AIM2 inflammasomes in Kupffer cells in hepatic ischemia/reperfusion. FEBS J, 2015, 282:259-270.
32 Diao L, Marshall AH, Dai X,et al.Burn plus lipopolysaccharide augments endoplasmic reticulum stress and NLRP3 inflammasome activation and reduces PGC-1α in liver. Shock, 2014, 41:138-144.
33 Witek RP, Stone WC, Karaca FG, et al.Pan-Caspase inhibitor VX-166 reduces firbosis in an animal model of nonalcoholic steatoehaptitis. Hepatology,2009,50:1421-1430.
34 Kamari Y, Shaish A, Vax E, et al.Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. J Hepatol,2011,55:1086-1094.
35 Peng Y, French BA, Tillman B, et al.The inflammasome in alcoholic hepatitis: Its relationship with body formation. Exp Mol Pathol, 2014,97:305-313. |
